We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 0.29% | 1,733.50 | 1,732.50 | 1,733.00 | 1,739.50 | 1,724.50 | 1,733.00 | 4,237,056 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.48 | 71.35B |
Date | Subject | Author | Discuss |
---|---|---|---|
19/2/2021 20:15 | Hence the so called markets are in casino mode... Poikka19 Feb '21 - 16:50 - 24857 of 24876 0 2 0 And that's the point now, Essential, credibility and trust have gone. | diku | |
19/2/2021 19:55 | Ceo has zero credibility inside the company never mind outside. | meijiman | |
19/2/2021 19:06 | Lols, you card ). | essentialinvestor | |
19/2/2021 19:05 | no chance - the despair has plenty of legs yet - especially after a weekend of contemplating all this doom and gloom | eurofox | |
19/2/2021 18:59 | Judging by the despair with the valuation I’d say we are at the bottom of the current downturn, would expect a dramatic bounce imminently. Saying that on the basis that sellers have held sway for over a week, and eventually it exhausts itself. | wormhasturned | |
19/2/2021 18:52 | I'd say most posts are positive for the medium term on here, anger at the CEO is not the same thing as losing faith in the company. How such positive sentiment ( Walmsley excepted)and minimal short activity has led to such a price meltdown is a mystery. Predicting the bottom is impossible but I"d bet on a rapid rebound when it does. | stewart64 | |
19/2/2021 18:34 | keep up the doom and gloom, new entrants need lower prices | eurofox | |
19/2/2021 18:10 | The share price is collapsing fast while everyday we have rns of directors vesting and selling their bonus shares. How can they deserve to have bonus while their performance are so abysmal? Shouldn't the bonus linked on the company performance? | ceaserxzy | |
19/2/2021 17:53 | Unilever and AZN are good comps | williamcooper104 | |
19/2/2021 17:52 | Only at 0.56 percent short covered it's hardly heavily shorted | williamcooper104 | |
19/2/2021 17:52 | I would not be surprised if the PE boys are pouring over their slide rules this weekend and burning the midnight oil. Normalised PE ratio currently 11.5 - for a pharma!! Astonishing. There is money to be made here. The other thought I had is this is right up Buffet’s street. I appreciate that it is such a cliche to trot out the “Buffet’ line when a share price is falling, but there is a lot about GSK that fits with his investment ethos. Just a thought ... | spyder | |
19/2/2021 17:45 | From over 18 quid to 12 (and who knows, lower still perhaps!) in the space of a year, is the stuff of penny stocks. I think most holders are also not impressed with the levels of remuneration that the senior management team are getting, for what can only be described as deeply unsatisfactory commercial performance. Anyway, lets see what next week brings. Of all my holdings, this was meant to be one of the dull ones.... :) | lovewinshatelosses | |
19/2/2021 17:41 | What's next for this pow | thomstar | |
19/2/2021 17:36 | GSK on sale!!!!! Fill your boots everyone it's a no brainer!! | barbar7619 | |
19/2/2021 17:21 | Lots of posters feeling the squeeze and a bit cheesed off with the huge share price fall lately. Look at the monthly chart for gsk and there is huge support at this level. After that we could be looking at 1000 area. Either way i think the monthly chart removes alot of the noise and certainly helps me take a more balanced and longer term investment decision. The current flow of negative frustration and dismay will in my opinion change in time and sentiment will change to the upside. | supermarky | |
19/2/2021 17:16 | Correct Stewart. CEO needs to walk, and not get her payoff because she has failed. Abject failure should not be rewarded. She has had plenty of time now. | geckotheglorious | |
19/2/2021 17:12 | Gsk did very well between 18-20 and has had awful 20-21. Way too gloomy imo, shingrix will be firing away again | daneswooddynamo | |
19/2/2021 16:54 | .. maximum pessimism - just how I like it | eurofox | |
19/2/2021 16:50 | And that's the point now, Essential, credibility and trust have gone. We really need a new CEO and a new Chairman. The 'leadership' is the big issue at the moment. GSK might come up with some corker drugs, and they might get the vaccine right with Sanofi, but the leadership has been found wanting. | poikka | |
19/2/2021 16:45 | 65 pence looks highly optimistic!!. Who am I to argue with very highly paid pharma sector analysts and their modelling tbf. | essentialinvestor | |
19/2/2021 16:27 | Why would you split the company. Each part would be worth small change to a competitor - another great British company gets swallowed up. Only wondering - have started following this as it appears oversold charts wise. Don't hold any stock... thankfully! | cw2000 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions